Knowledge at the heart of leadership
Welcome to Liftstream - Life Sciences Executive Search and Leadership Advisory

Allergan Adds Migraine Treatment with purchase of MAP Pharmaceuticals

Allergan today (23/1/13) said that it would buy US based MAP Pharmaceuticals in a $958m acquisition. Allergan is purchasing MAP Pharmaceuticals in cash and has paid a 60% premium on the closing share price of MAP. Allergan expects the deal … Continue reading

Posted in Pharmaceutical business | Tagged , , , , , , , , , , , | 1 Comment

Genesis 2012 – The Debate on UK Biotech

Authored by Karl Simpson The One Nucleus event hosted the annual conference and this year it rounded off with a debate. On the one side were the ‘Enablers’ and on the other was ‘Industry’, chaired respectively by SCRIP Intelligence’s Editorial … Continue reading

Posted in Pharmaceutical business | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | 1 Comment

40 Days Until Rare Disease Day!

Authored by James Sheppard There are 40 days until Rare Disease Day 2013, which is scheduled for February 28, 2013. This is the 6th year that it has been celebrated. The slogan for this year’s event is “Rare Disorders Without Borders”, which supports … Continue reading

Posted in Orphan Drugs and Rare Diseases | Tagged , , , , , , , , , | 1 Comment

Liftstream Life Science Newsletter January Edition

The January edition of the newsletter contains: >  Industry highlights from the past month including recent M&A Highlights >  A special feature on the Cambridge biotechnology Cluster (One Nucleus) >  An in-depth article examining the rise and rise in interim managers … Continue reading

Posted in M&A Finance and Funding, Orphan Drugs and Rare Diseases, Pharmaceutical business | Tagged , , , , , , , , | Leave a comment

13 Life Science Leaders to watch in 2013

Authored by Liftstream The life sciences industry has faced considerable challenges over the last few years and 2013 looks to be another tough year despite some improved optimism emanating out of certain companies and markets. Liftstream takes a look at … Continue reading

Posted in M&A Finance and Funding, Pharmaceutical business | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | Leave a comment

Liftstream Celebrates its 9th Anniversary

  Liftstream recently celebrated its 9th anniversary and we wanted to say a big thank you to all the clients, candidates, suppliers and advisors who have helped us achieve another great year of success. Liftstream continues to find new and … Continue reading

Posted in Pharmaceutical business, Recruitment Market | Tagged , , , , , | Leave a comment

Parexel Expands Regulatory Capability with Liquent Purchase

On the 27th December 2012, Parexel announced they had completed the purchase of Regulatory Submissions experts Liquent for $72m from Marlin Equity Partners. Liquent is a global provider of Regulatory Information Management solutions to more than 200 biopharmaceutical and life … Continue reading

Posted in M&A Finance and Funding, Pharmaceutical business | Tagged , , , , , , , , | Leave a comment

The Rise and Rise of Interim Managers in Life Sciences

Authored by Karl Simpson Over the past 20 years, the industrial world and the global workplace has witnessed one of the most dramatic changes in the way organisations assemble the requisite skills and experiences necessary to drive their businesses. Individuals … Continue reading

Posted in Recruitment Market | Tagged , , , , , , , , , , | Leave a comment

Shire expands HGT business with acquisition of Lotus Tissue Repair

  Shire started the new year with the acquisition of the US based Lotus Tissue Repair (Lotus). At the time of writing, no details regarding the purchase value have been published. Lotus is a privately held biotechnology company launched in … Continue reading

Posted in M&A Finance and Funding, Orphan Drugs and Rare Diseases, Pharmaceutical business | Tagged , , , , , , , , , | Leave a comment

The Resurgence of Gene Therapy

Authored by James Sheppard Gene therapy has a chequered past and is still capable of drawing strong opinions both for and against its use. The recently European approval of Glybera (UniQure) for the treatment of lipoprotein lipase deficiency (LPLD) has … Continue reading

Posted in General, Orphan Drugs and Rare Diseases | Tagged , , , , , , , , , , , , , , , , , , , , , , | Leave a comment




Contact Us

   Liftstream Ltd.
67 Grosvenor Street
London
W1K 3JN

   Tel: ​+44 (0)20 3178 5864
   info@liftstream.com

Register your CV

Apply for sector specific vacancies or request a confidential discussion



Registered in England No: 5009233
VAT: 843679292

Follow Us





Sitemap